n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Bone Loss, Osteoclastic in 11 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"To understand the involvement of osteoclastogenesis inhibitory factor (OCIF), also called osteoprotegerin (OPG), in the pathogenesis of bone destruction in rheumatoid arthritis (RA), we investigated the cytokine network involved in the production of OCIF by human fibroblast-like synovial (HFLS) cells from a patient with RA." | 7.71 | Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor. ( Higashio, K; Nakagawa, N; Tsuda, E; Yano, K; Yasuda, H, 2001) |
"To understand the involvement of osteoclastogenesis inhibitory factor (OCIF), also called osteoprotegerin (OPG), in the pathogenesis of bone destruction in rheumatoid arthritis (RA), we investigated the cytokine network involved in the production of OCIF by human fibroblast-like synovial (HFLS) cells from a patient with RA." | 3.71 | Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor. ( Higashio, K; Nakagawa, N; Tsuda, E; Yano, K; Yasuda, H, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krieger, NS | 2 |
Bushinsky, DA | 2 |
Jang, S | 1 |
Bak, EJ | 1 |
Kim, M | 1 |
Kim, JM | 1 |
Chung, WY | 1 |
Cha, JH | 1 |
Yoo, YJ | 1 |
Honda, K | 1 |
Collin-Osdoby, P | 1 |
Rothe, L | 1 |
Bekker, S | 1 |
Anderson, F | 1 |
Huang, Y | 1 |
Osdoby, P | 1 |
Ha, H | 1 |
Lee, JH | 1 |
Kim, HN | 1 |
Kim, HM | 1 |
Kwak, HB | 1 |
Lee, S | 1 |
Kim, HH | 1 |
Lee, ZH | 1 |
Frick, KK | 1 |
LaPlante Strutz, K | 1 |
Michalenka, A | 1 |
Suzuki, Y | 1 |
Nishiyama, T | 1 |
Hasuda, K | 1 |
Fujishiro, T | 1 |
Niikura, T | 1 |
Hayashi, S | 1 |
Hashimoto, S | 1 |
Kurosaka, M | 1 |
Lader, CS | 1 |
Flanagan, AM | 1 |
Manabe, N | 1 |
Oda, H | 1 |
Nakamura, K | 2 |
Kuga, Y | 1 |
Uchida, S | 1 |
Kawaguchi, H | 2 |
Chikazu, D | 1 |
Kumegawa, M | 1 |
Hakeda, Y | 1 |
Yano, K | 1 |
Nakagawa, N | 1 |
Yasuda, H | 1 |
Tsuda, E | 1 |
Higashio, K | 1 |
11 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Bone Loss, Osteoclastic
Article | Year |
---|---|
Stimulation of fibroblast growth factor 23 by metabolic acidosis requires osteoblastic intracellular calcium signaling and prostaglandin synthesis.
Topics: Acidosis; Animals; Bone Resorption; Boron Compounds; Calcium Signaling; Fibroblast Growth Factor-23; | 2017 |
Wogonin inhibits osteoclast formation induced by lipopolysaccharide.
Topics: Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Coculture Techniques; Cyclooxygenas | 2010 |
Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Carbonic Anhydrase II; Cathepsin K; Cell D | 2011 |
Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro.
Topics: Allantois; Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Chick Embryo; Chorion; C | 2002 |
alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis.
Topics: Animals; Antioxidants; Blotting, Western; Bone and Bones; Bone Marrow Cells; Bone Resorption; Carrie | 2006 |
Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro.
Topics: Acidosis; Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Calcium; Cells, Cultured; Cult | 2007 |
Effect of etidronate on COX-2 expression and PGE(2) production in macrophage-like RAW 264.7 cells stimulated by titanium particles.
Topics: Animals; Bone Resorption; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase Inhibitor | 2007 |
Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Topics: Antibodies, Monoclonal; Bone Marrow Cells; Bone Resorption; Cell Count; Cell Division; Cyclooxygenas | 1998 |
Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients.
Topics: Animals; Arthritis, Rheumatoid; Bone Resorption; Calcium; Cell Differentiation; Coculture Techniques | 1999 |
Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
Topics: Acid Phosphatase; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Bo | 2000 |
Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor.
Topics: Arthritis, Rheumatoid; Bone Resorption; Cells, Cultured; Culture Media, Conditioned; Dinoprostone; F | 2001 |